Biostar Pharmaceuticals Total Revenue

As of the most recent data (September 2017), BSPM shows a total revenue of $320K. That compares with $3.9M in the prior-year period — down 91.9% year over year. That is below the sector sector average of $1.3B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BSPM's total revenue is now $320K (was $3.9M) — a 91.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biostar Pharmaceuticals is outperforming or lagging.

The its sector sector average total revenue is about $1.3B. Biostar Pharmaceuticals is at $320K, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how BSPM stacks up against individual peers as well.

Tracking BSPM's total revenue over time shows whether Biostar Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $320K That compares with $3.9M in the prior-year period — down 91.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total revenue page, Stockcircle has Biostar Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $320K) with ownership activity and broader fundamentals.